RNA Biology

Various methods have detected miRNA-target interactions via immunoprecipitation of UV-crosslinked Argonaute ribonucleoprotein complexes, followed by intermolecular ligation of bound miRNAs to target strands, forming chimeric RNAs. To date, these methods have relied on conventional viral reverse transcriptases (RTs) to generate cDNAs for sequencing. However, crosslinked RNAs often retain adducts after purification, which can make them poor templates for viral RTs. Here, we adapted OTTR (Ordered Two-Template Relay) techniques to generate cDNAs from Ago2-bound RNAs. OTTR makes use of a modified retroelement-encoded RT, which is strongly processive even on templates with modifications or adducts. We show that this "OTTR-CLASH" method increases the frequency of generating chimeric RNAs compared to previous methods. We also developed an improved bioinformatic pipeline for analysis of these data, and we use this to catalog miRNA-target interactions not previously described in the literature. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=147 HEIGHT=200 SRC="FIGDIR/small/738487v1_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@13bc276org.highwire.dtl.DTLVardef@5beb41org.highwire.dtl.DTLVardef@b204e5org.highwire.dtl.DTLVardef@15f747d_HPS_FORMAT_FIGEXP M_FIG C_FIG

TEXT ABSTRACTCatalytic-RNA (cat-RNA) expressed from mobile DNA can record cellular events, such as the uptake of plasmids via horizontal gene transfer, by splicing a barcode onto 16S ribosomal RNA (rRNA) - a system termed RNA addressable modification (RAM). However, scaling RAM to record multiple simultaneous biological events requires large numbers of orthogonal cat-RNA whose signals reflect the biological features under investigation rather than variability arising from the barcode sequence. Here, we explore how to design orthogonal cat-RNA to record information about multiple plasmid-encoded traits in parallel. We show that cat-RNA having tRNA-derived barcodes with sequence variation in the anticodon stem-loop present greater signal consistency within Escherichia coli than mRNA-derived barcodes. When orthogonal cat-RNA designs harboring tRNA-derived barcodes were evaluated in Vibrio natriegens and Pseudomonas putida, increased variance was observed compared with Escherichia coli. Nevertheless, the signal consistency was sufficient to use these orthogonal cat-RNAs to report on the relative activities of four promoters and two origins of replication by sequencing barcoded-rRNA derived from the three organisms. These results show how RAM can be multiplexed to report on mobile DNA features in microbial communities and illustrate the importance of accounting for variability in RNA outputs when designing and interpreting multiplexed RNA barcoding data. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=88 SRC="FIGDIR/small/738544v1_ufig1.gif" ALT="Figure 1"> View larger version (29K): org.highwire.dtl.DTLVardef@406ebaorg.highwire.dtl.DTLVardef@259751org.highwire.dtl.DTLVardef@1f1512corg.highwire.dtl.DTLVardef@8384b_HPS_FORMAT_FIGEXP M_FIG C_FIG

Glioblastoma (GBM) is a highly lethal brain cancer with limited therapeutic durability, where the majority of patients develop recurrent or persistent disease after standard chemoradiotherapy. Meanwhile, tRNA-derived fragments (tRFs) have become increasingly relevant to cancer biology; however, their clinical relevance in GBM remains undefined. Here, we report that a specific family of tRFs, 5-tRNA halves (tiR5s) dominates the small RNA landscape of GBM patient tumors and associates with worse overall survival, post-therapeutic disease persistence, and pro-invasive proteogenomic pathways across two independent GBM patient cohorts. This association between elevated tiR5 levels and therapeutic resistance re-emerges in radiation-resistant GBM xenograft models. Our findings reveal that tiR5s are an underappreciated molecular feature of highly aggressive GBM tumors, supporting further investigation into their biological roles and prognostic utility in GBM. HighlightsO_LItiR5s are the predominant tRF family in primary GBM patient tumors C_LIO_LIElevated tiR5 expression distinguishes primary GBM tumors that develop persistent disease after first-line therapy C_LIO_LIRadiation-resistant GBM PDX models show elevated tiR5 expression C_LIO_LIElevated tiR5 expression associates with poor overall patient survival and pro-invasive molecular programs in GBM patient tumors C_LI Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/738483v1_ufig1.gif" ALT="Figure 1"> View larger version (54K): org.highwire.dtl.DTLVardef@184ddc1org.highwire.dtl.DTLVardef@1faadc2org.highwire.dtl.DTLVardef@a5ae02org.highwire.dtl.DTLVardef@1431506_HPS_FORMAT_FIGEXP M_FIG C_FIG

Background: Prospective pregnancy registries and biobanking infrastructures are essential for future translational studies investigating maternal, placental and offspring health. However, circulating nucleic acid analyses are highly sensitive to preanalytical variability, particularly regarding blood-collection tube type and sample processing conditions. We established a prospective pregnancy registry and biobanking workflow at Cruces University Hospital and evaluated the impact of preanalytical variables on circulating cell-free DNA (cfDNA) and cell-free RNA (cfRNA) preservation in maternal plasma collected at delivery. Methods: The Registry of Pregnant Women at Cruces University Hospital was designed as a prospective infrastructure integrating placental sampling, maternal blood collection and ethically controlled future access to maternal and offspring clinical data. Within this framework, peripheral blood samples from 50 women at delivery were simultaneously collected into EDTA, Norgen and Roche tubes. Plasma samples processed within or after 24 hours following collection underwent cfDNA/cfRNA extraction, electrophoretic profiling, fluorometric quantification and RT-qPCR analyses targeting different stress-related genes. Results: By the end of June 2026, 1,127 women had been prospectively recruited into the registry, with 661 plasma samples, 637 serum samples and 858 sets of four placental biopsies collected, processed and stored in the Basque Biobank. In the preanalytical substudy, EDTA tubes yielded higher cfDNA concentrations, likely reflecting reduced cellular preservation and genomic DNA contamination. In contrast, Roche tubes showed superior cfRNA preservation, with higher cfRNA concentrations and more consistent detection of the characteristic 5S rRNA peak compared with EDTA and Norgen tubes. Processing delays beyond 24 hours reduced cfRNA concentration, while associations between circulating transcripts and gestational age were more consistently detectable in preservative-containing tubes. Conclusions: Prospective infrastructures like ours offer strong foundation for large scale, long-term studies in the framework of the Developmental Origins of Health and Disease hypothesis. Technically, Roche tubes provided superior cfRNA preservation and enhanced sensitivity for detecting subtle biological associations, supporting the importance of standardized preanalytical workflows within prospective pregnancy biobanking resource.

Preeclampsia (PE), new onset hypertension after 20 weeks of gestation, affects 10% of all pregnancies in the U.S. and it is associated with progesterone deficiency, chronic inflammation, elevated angiotensin II type 1 receptor agonistic autoantibody (AT1-AA) and endothelial dysfunction. Progesterone, through its receptors, stimulates an anti- inflammatory protein called Progesterone Induced Blocking Factor (PIBF) which decreases during various pregnancy disorders. Therefore, this study was designed to test the hypothesis that a progestogen, in the form of 17-hydroxyprogesterone caproate, stimulates PIBF, lowers vasoactive mechanisms which reduces maternal blood pressure in women with early-onset preeclampsia (EOPE). PE women received 17-OHPC (250 mg, I.M.) and blood draws were collected before and after 17-OHPC supplementation. Placentas were collected at the delivery. 17-OHPC prolonged time of delivery beyond 72h on average and maternal blood pressure was significantly decreased in PE+17- OHPC. Progesterone and PIBF levels were reduced in PE group vs. NP group. Importantly, 17-OHPC increased PIBF and decreased vasoactive mechanisms and markers of inflammation. In conclusion, 17-OHPC or progesterone supplementation improves maternal outcomes in response to EOPE without causing further harm to the fetus.

Cells must be primed to rapidly induce inflammatory gene expression upon infection while also tuning the level of induction to avoid immunopathology. Here, we identify RNA polymerase III (Pol III), best known for transcribing noncoding RNAs, as a dual-function regulator of RNA polymerase II (Pol II)-dependent inflammatory gene expression. Pol III is selectively enriched at promoters of innate immune, pro-inflammatory, and stress-response genes, where it maintains chromatin accessibility and supports basal transcription. Upon infection with murine gammaher-pesvirus 68 (MHV68), Pol III redistributes from these promoters to retrotransposon loci, coinciding with enhanced expression of inflammatory genes. Depletion of the Pol III transcription factor Brf1 further amplifies inflammatory transcription during infection with MHV68, herpes simplex virus-1, and influenza A virus. Genes restrained by Pol III have TATA-box-enriched promoters and are functionally dependent on TATA-binding protein (TBP), suggesting that Pol III modulates inflammatory gene expression by competing with Pol II for shared transcriptional machinery. Thus, Pol III is a chromatin licensor in uninfected cells and an inflammation rheostat during viral infection. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=178 SRC="FIGDIR/small/738346v1_ufig1.gif" ALT="Figure 1"> View larger version (43K): org.highwire.dtl.DTLVardef@d99325org.highwire.dtl.DTLVardef@4b781dorg.highwire.dtl.DTLVardef@bad1b6org.highwire.dtl.DTLVardef@11e41a6_HPS_FORMAT_FIGEXP M_FIG C_FIG

Introduction Accurate measurement of blood loss after caesarean birth is important for early identification of postpartum haemorrhage. Commonly used visual estimation underestimates blood loss. We compared two methods for objectively assessing blood loss. Methods Measured blood loss was obtained by weighing swabs and pads combined with blood from suction and drapes. Calculated blood loss was derived from maternal weight and peripartum haemoglobin change. Data were from the I'M WOMAN trial investigating tranexamic acid for postpartum haemorrhage prevention. This was a secondary analysis of prospectively collected trial data. We reported median (IQR) blood loss, assessed agreement using Bland-Altman analysis and compared the percentages of women exceeding 500 ml, 1000 ml and 1500 ml. We graphed proportional haemoglobin drop by categories of measured blood loss, stratified by anaemia status. We compared AUCs for measured and calculated blood loss predicting haemodynamic compromise (shock index above 1.0) and death or near-miss. Results A total of 10,393 women were included in this study. Median measured and calculated blood loss were 545 ml (IQR 430-700) and 505 ml (IQR 180-908) respectively, with weak correlation (Spearmans rho=0.28). The IQR was wider for calculated blood loss than for measured blood loss, indicating greater variability. Bland-Altman analysis showed a small mean bias of -39 ml but wide limits of agreement (lower -1196 ml, upper 1118 ml). Measured versus calculated blood loss exceeded 500 ml in 60% versus 51% of women, 1000 ml in 7% versus 21%, and 1500 ml in 2% versus 8%. Women without anaemia had a greater proportional haemoglobin drop than women with anaemia for blood losses below 1000 ml. Measured blood loss had better predictive ability for death or near-miss (AUC 0.87 vs 0.76, p<0.001) and haemodynamic compromise (AUC 0.66 vs 0.62, p=0.001). Conclusion While median measured and calculated blood losses were similar, they were only weakly correlated. Calculated blood loss classified more women as having blood loss above higher thresholds. Women without anaemia had a greater proportional haemoglobin drop than women with anaemia for blood loss below 1000 ml. Measured blood loss had a modest advantage in predicting death or near-miss and haemodynamic compromise, but calculated blood loss remains an objective measure suitable as a trial outcome when direct measurement is not feasible.

Background: Antimicrobial resistance (AMR) disproportionately affects low- and middle-income countries (LMICs) such as Pakistan, where obstetric and gynaecological (OBGYN) patients carry high antibiotic exposure. Specialty-specific drug utilization data with concurrent stewardship audit remain scarce. This study evaluated antibiotic prescribing patterns, consumption metrics, and antimicrobial stewardship program (AMS) compliance in OBGYN inpatients at a public sector tertiary care hospital. Methods: A prospective cross-sectional study was conducted in OBGYN wards of Dow University Hospital, Karachi, from 1 September to 31 October 2025. Women receiving [&ge;]1 systemic antibiotic were included. Daily AMS rounds were conducted by an Infectious Diseases physician and pharmacist. Antibiotic consumption was measured as Defined Daily Doses (DDD) and Days of Therapy (DOT) per 1,000 patient-days (total = 821). Antibiotics were classified by WHO AWaRe (2023) framework. Results: Of 812 total admissions, 278 patients (34.2%) received [&ge;]1 antibiotic and were enrolled (205 obstetric, 73 gynaecological), generating 636 prescriptions (mean 2.29/patient). Surgical prophylaxis was the predominant documented indication (213, 33.5%); 65.1% carried no documented indication. By AWaRe classification, 53.6% were Access-group and 46.1% Watch-group. Ceftriaxone (38.4%) and metronidazole (36.8%) together represented 75.2% of prescriptions. Combined DDD/1,000 patient-days was 1,758.6 and DOT/1,000 patient-days was 1,852.7. AMS compliance was 0%. Conclusions: This study documents high antibiotic prescribing burden, near-universal documentation failure, and zero AMS compliance in OBGYN inpatients at a Pakistani public sector hospital. The predominance of Watch-group antibiotics and undocumented surgical prophylaxis highlights structural stewardship gaps. Findings support urgent need for institutional OBGYN antibiotic guidelines and structured pharmacist-led AMS programs.

Cell-free protein synthesis (CFPS) is a powerful platform for synthetic biology, yet the factors governing reaction longevity remain poorly understood despite their importance for high-throughput applications. Here, the three principal determinants of CFPS performance--DNA template design, reaction composition, and lysate genotype--were systematically optimized to extend reaction lifetime in a 384-well plate format. Different energy regeneration systems were evaluated through real-time pH monitoring and metabolomic analyses to identify the metabolic constraints limiting prolonged protein synthesis. Lysates prepared from engineered Escherichia coli BL21(DE3) strains were further examined to assess the contributions of DNA, RNA, and amino acid stabilization. Systematic optimization of amino acid, nucleoside triphosphate, polyethylene glycol, and lysate concentrations identified DNA template stability and amino acid preservation as the primary factors sustaining CFPS activity. Combining these improvements yielded reactions that remained productive for >14 h and produced 567 {+/-} 64 g mL-1 active deGFP. These findings establish practical strategies for extending CFPS lifetime and improving high-throughput cell-free platforms.

Background: Anemia during pregnancy remains a major public health concern, particularly in low- and middle-income countries, where it contributes substantially to maternal and neonatal morbidity and mortality. Identifying women at increased risk is essential for timely intervention and improved pregnancy outcomes. Objective: This study aimed to identify the significant predictors of anemia among pregnant women using logistic regression and to evaluate the association between selected clinical and sociodemographic characteristics and anemia. Methods: A cross-sectional study was conducted using secondary data obtained from a community maternity care facility in the Suame Municipality of the Ashanti Region, Ghana. Pregnant women who attended antenatal care during the study period and had complete information on hemoglobin concentration and relevant predictor variables were included. Women with missing hemoglobin measurements at registration or delivery were excluded. Logistic regression analysis was performed to identify independent predictors of anemia. Additional analyses examined the effects of age and weight, as well as the relationship between sickle cell status and blood group. Results: Logistic regression identified diastolic blood pressure, height, hemoglobin concentration at registration, maternal weight and gestational age as significant predictors of anemia during pregnancy (p < 0.05). Although employment status was statistically significant in the model, its direct association with anemia was relatively weak. Maternal age was not significantly associated with anemia. Pregnant women with sickle cell disease had a significantly higher likelihood of anemia. Blood group did not demonstrate a significant relationship with anemia. Effect sizes and confidence intervals were not available in the dataset. Conclusion: Diastolic blood pressure, height, hemoglobin concentration at registration, maternal weight, gestational age, sickle cell status and employment status were identified as important predictors of anemia during pregnancy. These findings highlight the importance of incorporating both clinical and sociodemographic characteristics into antenatal risk assessment and screening programs. Further prospective studies with larger sample sizes and more comprehensive clinical measurements are recommended to validate these findings and strengthen predictive models for anemia during pregnancy.

Introduction: Oxytocin is commonly used in the process of induction of labour and is associated with uterine hyperstimulation and abnormal fetal heart rate patterns that can increase the risk of adverse perinatal outcomes. Cessation of oxytocin in the active phase of induced labour has been shown in randomised trials to reduce uterine tachysystole and abnormal fetal heart rate traces, and may reduce caesarean section. We introduced a policy recommending cessation of oxytocin infusion in the active phase of the first stage of induced labour at a tertiary hospital in Sydney, Australia, and collated both clinical outcomes and maternal satisfaction following implementation. Methods: This was a prospective audit of a policy change at Royal Prince Alfred Hospital, comparing 600 women induced with oxytocin in the 6 months before the policy (November 2019 to May 2020) with 556 women induced in the 6 months after implementation (June to December 2020). Eligible women had a cervix [&ge;] 5cm, an oxytocin infusion, and regular uterine contractions. The primary clinical outcome was caesarean delivery. The primary patient-centred outcome, maternal satisfaction, measured using the Six Simple Questions questionnaire, was collected in a subset of participants. Secondary outcomes included mode of birth, length of labour, uterine hyperstimulation, and perinatal outcomes. Results: Caesarean delivery occurred in 29% of women before and 28% after policy implementation (p=0.77). Instrumental birth increased from 25% to 27%; and instrumental birth for maternal indications increased from 6.8% to 13% (p=0.0005). Median length of labour increased by one hour (5.4 vs 6.4 hours, p=0.006). Oxytocin was ceased for at least two hours or until birth in 13% of women before the policy versus 35% after. Maternal satisfaction scores were modestly lower after implementation (median 41 vs 38, p=0.03). Perinatal outcomes, including abnormal cord gases, Apgar scores, and NICU admission, were similar between groups. Conclusions: Implementing a policy of recommending cessation of oxytocin in the active phase of induced labour did not reduce caesarean delivery rates in a real-world tertiary hospital setting, despite trial-level evidence supporting the intervention. Poor uptake, negative staff perceptions, and a modest reduction in maternal satisfaction highlight barriers to translating trial efficacy into routine clinical practice. Adequately powered trials are needed to clarify optimal protocols for oxytocin cessation and its effects on maternal and perinatal outcomes.

Background Menstrual cycle disturbances have been increasingly reported after COVID-19 vaccination, raising questions about their prevalence and clinical significance among women of reproductive age. Objective This study aimed to investigate the incidence and types of menstrual cycle alterations following different doses of COVID-19 vaccines among Iranian women of reproductive age. Methods A cross-sectional survey was conducted among vaccinated women who reported their menstrual cycle status before and after each vaccine dose. Data on cycle regularity, flow characteristics, and specific menstrual disorders were collected and analyzed. Results Menstrual cycle alterations were reported by 28.8%, 25.4%, 30.3%, and 68.4% of participants after the first, second, third, and fourth vaccine doses, respectively. The most common changes were oligomenorrhea after the first and second doses (8.9% and 5.6%), menorrhagia after the third dose (5.3%), and hypomenorrhea after the fourth dose (8.3%). Comparisons with international studies revealed a wide variation in prevalence (ranging from 25% to 78%), which may be explained by differences in methodology, population characteristics, vaccine types, and pre-vaccination health status. Conclusion A considerable proportion of Iranian women experienced menstrual alterations following COVID-19 vaccination, most commonly oligomenorrhea, menorrhagia, and hypomenorrhea. While generally self-limiting, these findings highlight the need to integrate menstrual health into post-vaccination monitoring and patient counseling. Future research should explore the underlying immune-endocrine mechanisms and long-term clinical implications of these changes.

BACKGROUND: Since South Africa's democratic transition in 1994, the country has undergone profound social, demographic and public health change. We analysed national recorded live-birth data from 1994-2024 to identify major signals of population reproduction. METHODS: Monthly recorded live births from January 1994 to December 2024 were obtained from Statistics South Africa. Birth seasonality, sex ratio at birth (SRB) [male/total live births] and annual recorded live births were analysed using time-series and forecasting methods. RESULTS: From 1994-2014, September was the peak birth month in all 21 years, consistent with conceptions during the Christmas-New Year holiday period nine months earlier. From 2015 onwards, March became the most frequent peak month, with April emerging as the peak month in 2024, indicating a shift towards winter conceptions. The SRB declined to 49.996% in June 2021 (95% prediction interval 50.165%-50.749%) and remained below the lower prediction bound from May to July 2021 (combined p<0.001). November 2021 recorded the highest monthly SRB in the 31-year study period (50.983%), exceeding the upper 95% prediction interval. Annual recorded live births peaked at 1,112,378 in 2008 and declined to 798,556 in 2024; births from 2022-2024 fell below the 95% confidence interval of the historical trend. CONCLUSIONS: Three prominent demographic signals emerged: a shift from Christmas holiday conceptions towards winter conceptions; a rare inversion (SRB <50%) and sustained depression of the SRB during May-July 2021, occurring within the 3-5-month stress-sensitive window after the January 2021 Beta-wave mortality peak, followed by the highest monthly SRB of the study period in November, nine months after the easing of COVID-19 restrictions in February 2021; and an accelerated decline in annual recorded live births after 2021, culminating in the lowest level observed in 2024. These findings indicate changes in reproductive timing, stress-sensitive sex-ratio patterning and fertility in South Africa.

In Mongolia, an average of 65,000 women become pregnant each year, and about 59,500 babies are born. Although the number of pregnancies is decreasing by 8-12 percent each year, the level of fetal monitor usage remains high. The capital's maternity hospital currently has 27 fetal monitors in use, and an average of 30-35 calls are recorded per month. However, there is a lack of research on the use of fetal monitors, the causes and influencing factors of damage, and the organization of technical services. Therefore, this topic was chosen to determine the usage status of fetal monitors, the causes of malfunctions, and ways to improve them. Purpose To study the causes and factors affecting possible damage and injury during the use of fetal monitors, and to identify ways to reduce them. Materials and methods A one-time study was conducted on 10 MT-610 fetal monitors that were put into operation in 2019 at the Urgo Maternity Hospital in the capital. Data were collected and processed using document analysis methods from the technical passports and call logs of these devices. The factors contributing to common failures were identified using focus group interviews with the engineers and technicians responsible for the equipment. Results This study found that fetal monitor failures are caused by improper use, lack of regular calibration, electrical fluctuations, ambient temperature and humidity, and insufficient medical staff skills, training, and knowledge of how to use the device, all of which contribute to failures and measurement errors. It is also observed that when a replacement part is needed for a monitor that frequently breaks, the monitor is more likely to break again if it is used as a replacement from a previously broken monitor. Therefore, training doctors and nurses who replace spare parts on their use has been observed to significantly reduce future breakdowns. Conclusion According to the study results, the breakdowns and failures of fetal monitoring devices are mainly related to internal system failures, unstable power supply, and wear and tear of accessories and mechanical parts. The highest percentage of device failures indicates the need for special attention to the reliability of the device's basic functions. Additionally, the high percentage of accessory and printer failures indicates the need for proper use and monitoring of the entire device. In addition to technical factors, human misuse, lack of maintenance, and environmental influences also play a significant role in damage. Therefore, it is concluded that to ensure the reliable operation of fetal monitors, it is necessary to perform regular maintenance, stabilize the power supply, improve the quality of accessories, and increase the knowledge and skills of medical staff. Keywords: Fetal Monitoring, Equipment Failure, Risk Factors

There remains considerable uncertainty around the safety of a trial of labour after more than one caesarean delivery. This large retrospective cohort study will investigate the safety of a trial of labour using a large United States dataset of all registered births from 2011 to the most recent year with available data. A multivariable fitted model will be used to predict the probability of uterine rupture in women with two or more previous caesarean deliveries, with a minimum 21-month interpregnancy interval. This will provide important information to clinicians in counselling women wanting to attempt a vaginal birth after more than one caesarean delivery.

BACKGROUND In line with International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) recommendations for high-sensitivity cardiac troponin assays, analytical validation and reference limit assessments are required to confirm that an assay meets performance criteria. This study evaluated the analytical performance and established the 99th percentile upper reference limit (URL) for the SPINCHIP High-Sensitivity Cardiac Troponin I (SPINCHIP hs-cTnI) point-of-care assay. METHODS Analytical performance characteristics, including the limit of blank (LoB), limit of detection (LoD), and limit of quantification (LoQ), were assessed. Additionally, 1,053 plasma samples and 1,055 whole-blood samples were used to determine the URL. Imprecision around the 99th percentile URL was evaluated as part of the analytical validation. High-sensitivity criteria were assessed by confirming measurable cTnI in [&ge;]50% of healthy individuals (n=432 plasma; n=431 whole blood) and achieving imprecision <10% at the 99th percentile (plasma, n=960; whole blood, n=480). RESULTS SPINCHIP hs-cTnI demonstrated a LoB of 0.3 ng/L; LoDs of 0.8 ng/L (plasma) and 0.9 ng/L (whole blood); and LoQs of 1.1 ng/L (plasma) and 1.4 ng/L (whole blood). The analytical measuring range was 1.1-9,000 ng/L. Imprecision at the common 99th percentile URL (14 ng/L) was 5.8%; for men (URL=16 ng/L) 5.6% and for women (URL=10 ng/L) 6.3%. Greater than 85.2% (94.0% and 76.1% in men and women, respectively) of healthy individuals showed measurable cTnI above the LoD. CONCLUSIONS The SPINCHIP hs-cTnI assay meets the IFCC high-sensitivity requirements, demonstrating <10% imprecision at the 99th percentile, reliable low-concentration precision and cTnI detection in more than half of healthy individuals.

Objective: To assess the feasibility of a definitive randomised controlled trial comparing halved versus routine-concentration oxytocin infusion during active phase of the first stage of labour in women undergoing induction of labour. Design: Multicentre, double-blind, randomised feasibility trial with 1:1 allocation. Participants: Women & birthing people aged 18 years or older undergoing planned induction of labour in two public maternity hospitals in Sydney, Australia, between September 2023 and September 2025 were eligible. Key exclusions included previous caesarean delivery, pre-existing diabetes, major fetal anomaly, abnormal fetal cardiotocography, malpresentation, suspected cephalopelvic disproportion, suspected chorioamnionitis, intrapartum pyrexia, and other predefined maternal or fetal safety concerns. Interventions: All participants commenced induction with standard oxytocin during the latent phase (10 IU in 1 L crystalloid). At established active labour, participants were randomised to receive either halved-concentration oxytocin (5 IU in 1 L crystalloid) or routine-concentration oxytocin (10 IU in 1 L normal saline), titrated according to the New South Wales (NSW) Health oxytocin protocol between one and 40 mIUmin-1. Main outcome measures: Feasibility outcomes were recruitment, consent, randomisation, retention, protocol adherence, unblinding, and treatment separation, assessed by total oxytocin dose and infusion rates. Secondary outcomes included maternal, neonatal, and participant-reported outcomes. Results: Of 771 women assessed for eligibility in two centres, 572 were approached and 293 (51%) consented to participate, of whom 101 (34%) were randomised. During active recruitment, randomised participants represented 9.2% of all births. Baseline characteristics were similar between groups. No between-group differences were observed in maternal, neonatal, or participant-reported outcomes, although the trial was not powered to assess clinical effectiveness. Satisfaction outcomes were ascertained for 69% (70/101) participants. There was 100% ascertainment for short-term clinical outcomes and for readmissions to the hospital of delivery. Twenty-nine participants were interested in providing feedback and in being involved in developing a larger study across multiple hospitals. Conclusions: A blinded randomised controlled trial of oxytocin dose reduction in active labour is feasible in a real-world labour ward. Trial registration: This trial was registered on the ANZCTR (ACTRN12622001342707)

"Mirror life", self-replicating organisms composed of non-natural-chirality biomacromolecules, presents a future threat with potentially global consequences. Consequently, there is strong agreement among experts that it should not be created. However, there is some disagreement over how effective existing medical countermeasures might prove against mirror bacteria in the event that they were created. Here, we leverage computational chemistry methods including docking and molecular dynamics to determine the likely binding efficacy of existing antibiotics against natural and mirror bacterial protein targets. We find that most existing antibiotics fail to bind to mirror bacterial protein targets, unlike their natural-chirality targets. This suggests altered binding of current medical countermeasures, which may impact the antimicrobial activity against mirror bacteria were the latter were created.

Co-transcriptional splicing is a conserved feature of eukaryotic gene expression. However, establishing the functional nature of this process has been difficult. Here using high throughput CRISPR/Cas9 screens we surprisingly find that SF3B3, the third largest subunit of the U2 snRNP complex, is a major regulator of RNA Pol II pause release and processivity. Remarkably, the absence of SF3B3 dramatically perturbs transcription but U2 snRNP assembly and RNA splicing remains unaffected. Mechanistically, SF3B3 coordinates the chromatin occupancy of transcriptional kinases (CDK9/12/13) alongside the PAF1c and Integrator complexes to regulate Pol II. Structure / function analyses of SF3B3 revealed that a metazoan specific 18aa sequence within its disordered tail phenocopies its loss and mediates the physical association and stability of SF3B5. We show that loss of SF3B5 mirrors SF3B3 deficiency suggesting this submodule, although resident within the U2 snRNP complex, evolved to primarily coordinate RNA Pol II in a splicing-independent manner.

Retrons are prokaryotic genetic elements that protect bacterial cells from invading phages. The type IX retron comprises a non-coding RNA, a reverse transcriptase (RT), and dual effectors: a putative HEPN nuclease and a winged helix-turn-helix (WH) protein. Here, we show that the type IX retron system from Klebsiella variicola cleaves host rRNAs and tRNAs upon phage infection, mediating anti-phage defense via an abortive-infection mechanism. Cryo-electron microscopy analysis reveals that the RT, HEPN, and WH proteins, along with multicopy single-stranded DNA (msDNA), form a unique, sheet-like supermolecular complex. Notably, the HEPN active site is encircled by the WH and msDNA within the complex, suppressing the nuclease activity prior to phage infection. A phage-encoded exonuclease cleaves the msDNA, likely releasing the HEPN nuclease to cleave host RNAs and induce growth arrest in infected cells. Overall, these findings highlight the structural and functional diversity of prokaryotic anti-phage defense systems.